ECLEcolab
$281.83+7.3% 1Y
$281.83
$245.0652 weeks$306.69
ECL as reported
Ecolab reported $16.8B of revenue over the trailing twelve months, +7.1% on the year before. 11 reported series are charted on this page, each one as filed.
$16.8B
Revenue, trailing twelve months · to Q2 2026 · +7.1% against the twelve months before
- Net income
- $2.13B
Net income · −1.0% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $1.87B
Free cash flow · +19% year on year · trailing twelve months to Q2 2026
- Operating margin
- 17%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $16.8B | +7.1% | Q2 2026 |
| Net income | $2.13B | −1.0% | Q2 2026 |
| EPS | $7.45 | −0.53% | Q2 2026 |
| Gross margin | 44% | n/a | Q2 2026 |
| Operating margin | 17% | n/a | Q2 2026 |
| Net margin | 13% | n/a | Q2 2026 |
| ROE | 21% | n/a | Q2 2026 |
| ROA | 8.1% | n/a | Q2 2026 |
| ROIC | 13% | n/a | Q2 2026 |
| Free cash flow | $1.87B | +19% | Q2 2026 |
| P/E | 37.8 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Ecolab (ECL) · Revenue and profitRevenue and profitEcolab (ECL)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
On our screens:Stocks that buy back more than they dilute
Specialty Chemicals
The closest names by size in the same industry